drugset / Trial / NCT01458431

Levobupivacaine to the Surgical Wound Following Cesarean

NCT01458431

Phase 3 Completed 70 enrolled Manuel Ángel Gómez-Ríos
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The postoperative period following cesarean is associated with moderate to severe pain that requires a considerable amount of analgesics that carry with them side-effects such as nausea, vomiting, fatigue and immobilization. Several studies have tried, with variable results, to find a more effective analgesia alternative such as infusion of local anesthetics through a catheter in the surgical wound sinus, a practice that has currently been widely used in clinical practice. Despite existing references on its use in the postoperative period following cesareans there continues to be a lack of information on other aspects. The investigators study hypothesis is that the use of levobupivacaine in the surgical wound will reduce the surface of hyperalgesia compared to the control group.

Timeline

Start
2011-10
Primary completion
2014-09
Completion
2014-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Levobupivacaine Other / unclassified 0.35 % Other

Indications

No indication recorded.